FDA Warns 3 Infant Formula Companies Over Safety Standards

The FDA issued warning letters to three prominent infant formula manufacturers in a bid to bolster safety standards in the infant formula industry.

A sign for the Food and Drug Administration (FDA) outside of the headquarters in White Oak, Md., on July 20, 2020. Sarah Silbiger/Getty Images

The U.S. Food and Drug Administration (FDA) issued warning letters on Wednesday to three prominent infant formula manufacturers in a bid to bolster safety standards within the infant formula industry.

The letters were sent to ByHeart, Mead Johnson Nutrition, and Perrigo Wisconsin. Inspections of their facilities uncovered violations of FDA health regulations, which led to voluntary recalls in December 2022, February, and March.